CITADEL ADVISORS LLC 13D and 13G filings for VistaGen Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:19 pm Sale | 2024-09-30 | 13G | VistaGen Therapeutics, Inc. VTGN | CITADEL ADVISORS LLC | 1,158,219 4.200% | -442,549 (-27.65%) | Filing |
| 2024-02-14 6:18 pm Purchase | 2023-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | CITADEL ADVISORS LLC | 1,600,768 5.800% | 6,832 (+0.43%) | Filing |
| 2023-10-16 4:01 pm Purchase | 2023-10-04 | 13G | VistaGen Therapeutics, Inc. VTGN | CITADEL ADVISORS LLC | 1,593,936 5.700% | 1,593,936 (New Position) | Filing |